According to lengthy AI searches, "SCENESSE’s social media chatter largely originates from or is amplified by Clinuvel’s own promotional and informational campaigns rather than organic or independent social media discussions outside of the company’s influence. There is no clear evidence from the search results that SCENESSE is widely discussed on social media independently of Clinuvel’s promotional activities. Most mentions and visibility seem linked to Clinuvel’s investor relations efforts, clinical trial announcements, and participation in medical conferences, which they actively publicize through their corporate communications and social media." FWIW...
CUV Price at posting:
$9.90 Sentiment: Hold Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)